High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma

Published:2018-09-27 Issue:7 Volume:118 Page:1115-1121
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Zhou Li¹^ORCID,Lu Jun¹,Liang Zhi-Yong²,Zhou Wei-Xun²,Yuan Da¹,Li Bing-Qi¹,You Lei¹,Guo Jun-Chao¹,Zhao Yu-Pei¹

Affiliation:

1. Department of General Surgery; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College; Beijing China

2. Department of Pathology; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College; Beijing China

Funder

CAMS Innovation Fund for Medical Sciences (CIFMS), China

National High Technology Research and Development Program (863 Program), China

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.25253/fullpdf

Reference40 articles.

1. Pancreatic adenocarcinoma;Ryan;N Engl J Med,2014

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure;Mitchem;J Am Coll Surg,2012

4. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01);Uesaka;Lancet,2016

5. Five-year actual overall survival in resected pancreatic cancer: a contemporary single-institution experience from a multidisciplinary perspective;Picozzi;Ann Surg Oncol,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies;Molecular Cancer Therapeutics;2023-06-09

2. Expression of mir-25-3p, CARD9 and surviving in acute pancreatitis and predictive value for patient outcome;Cellular and Molecular Biology;2023-01-31

3. The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer;Cancers;2022-10-22

4. Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma;Cancers;2022-07-18

5. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review;International Journal of Molecular Sciences;2022-02-14